Beam Therapeutics Inc. (BEAM) /
The debt of Beam Therapeutics Inc. over the past 7 years
Chart Beam Therapeutics Inc.: liquid cash, total debt, net cash, fiscal 2019–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Beam Therapeutics Inc. had liquid cash of $1.25B and total debt of $0: net cash of $1.25B. It had more liquid cash than debt at all 7 year-ends shown.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $1.25B* | $0 | $1.25B |
| 2024ended Dec 31, 2024 | $850.74M* | $0 | $850.74M |
| 2023ended Dec 31, 2023 | $1.19B* | $0 | $1.19B |
| 2022ended Dec 31, 2022 | $1.08B* | $0 | $1.08B |
| 2021ended Dec 31, 2021 | $965.65M* | $0 | $965.65M |
| 2020ended Dec 31, 2020 | $299.67M* | $0 | $299.67M |
| 2019ended Dec 31, 2019 | $91.85M* | $0 | $91.85M |
Fiscal years as Beam Therapeutics Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Beam Therapeutics Inc.
- The revenue of Beam Therapeutics Inc.
- The profitability of Beam Therapeutics Inc.
- The cash flow of Beam Therapeutics Inc.
- All of Beam Therapeutics Inc.'s financials, charted
Companies of a similar size
- CLSKCleanSpark, Inc.
- ADEAADEIA INC.
- QSQUANTUMSCAPE CORPORATION
- BHFBrighthouse Financial, Inc.
- UPSTUpstart Holdings, Inc.
Not investment advice. This page shows what Beam Therapeutics Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.